Vaccination design based on natural env genes to elicit broad neutralizing Abs
$513,861P01FY2011AINIH
Oregon Health & Science University, Portland OR
Investigators
Linked publications & trials
Paper 35173151Paper 32582155Paper 30566528Paper 27509243Paper 26944928Paper 26599989Paper 25730345Paper 25210191Paper 25210168Paper 25122781Paper 24358343Paper 24280279Paper 22749601Paper 19672890
Abstract
This project seeks to develop novel vaccines that can be delivered as DNA vaccine components to produce strong neutralizing antibodies. The immunity produced by these vaccines, if successful, can be optimized and then tailored to work in combination with other HIV vaccines to vaccinate at-risk populations and reduce acquisition or severity of HIV.
View original record on NIH RePORTER →